| P50 | author | Jeffrey F Scherrer | Q56944765 |
| P2093 | author name string | Lisa A Davis | |
| | Hong Xian | |
| | Liron Caplan | |
| | Seth A Eisen | |
| | Angelique L Zeringue | |
| | Jay R McDonald | |
| | Francesca E Cunningham | |
| | Kent R Wehmeier | |
| | Cory B Pittman | |
| | Alexis Arnold | |
| P2860 | cites work | Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis | Q24600663 |
| | Osteoporosis, inflammation and ageing | Q24815520 |
| | The effect of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on a rabbit model of athero-arteriosclerosis | Q28329792 |
| | Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data | Q30926045 |
| | Identification of individuals with CKD from Medicare claims data: a validation study | Q31000968 |
| | A study to determine the sensitivity and specificity of hospital discharge diagnosis data used in the MICA study | Q33201314 |
| | Validation of a case definition to define hypertension using administrative data | Q33512674 |
| | Bisphosphonate Use and Prevalence of Valvular and Vascular Calcification in Women MESA (The Multi-Ethnic Study of Atherosclerosis). | Q34418799 |
| | The prevalence of osteoporosis: gender and racial comparison | Q34454691 |
| | Bone density and hyperlipidemia: the T-lymphocyte connection | Q35229853 |
| | Diabetes Mellitus: Does it Affect Bone? | Q35546778 |
| | Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link? | Q35700564 |
| | Male osteoporosis: epidemiology and pathophysiology | Q36203210 |
| | Cardiovascular disease and osteoporosis. | Q36427035 |
| | Coronary artery calcium scanning: Clinical paradigms for cardiac risk assessment and treatment | Q36509559 |
| | Periodontal disease and systemic conditions: a bidirectional relationship. | Q36602669 |
| | Extra-skeletal effects of bisphosphonates | Q36695849 |
| | Positive predictive value of ICD-9 codes 410 and 411 in the identification of cases of acute coronary syndromes in the Saskatchewan Hospital automated database | Q37170881 |
| | Association of coronary artery and aortic calcium with lumbar bone density: the MESA Abdominal Aortic Calcium Study | Q37306185 |
| | Relation of bisphosphonate therapies and risk of developing atrial fibrillation | Q37408617 |
| | The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology | Q38069009 |
| | Osteoclast formation, survival and morphology are highly dependent on exogenous cholesterol/lipoproteins | Q40579083 |
| | An assessment of the validity of ICD Code 410 to identify hospital admissions for myocardial infarction: The Corpus Christi Heart Project | Q41215745 |
| | Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. | Q42543174 |
| | Beneficial effect of risedronate on arterial thickening and stiffening with a reciprocal relationship to its effect on bone mass in female osteoporosis patients: A longitudinal study | Q42857094 |
| | Osteoporosis treatment and atrial fibrillation: alendronate versus raloxifene. | Q43292239 |
| | Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption | Q43604722 |
| | Immortal time bias in observational studies of drug effects | Q44123059 |
| | Changes in serum HDL and LDL cholesterol in patients with Paget's bone disease treated with pamidronate | Q44313214 |
| | Relationship between lipids and bone mass in 2 cohorts of healthy women and men. | Q44688641 |
| | Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis | Q45071565 |
| | Accuracy of Veterans Administration databases for a diagnosis of rheumatoid arthritis | Q45333297 |
| | Aortic calcification and the risk of osteoporosis and fractures | Q46548686 |
| | Effect of long-term treatment with risedronate on arterial compliance in osteoporotic patients with cardiovascular risk factors | Q46565319 |
| | Inhibition of the progression of aortic calcification by etidronate treatment in hemodialysis patients: long-term effects | Q48508003 |
| | Chronic intravenous aminobisphosphonate therapy increases high-density lipoprotein cholesterol and decreases low-density lipoprotein cholesterol. | Q51557273 |
| | Effect of etidronic acid on arterial calcification in dialysis patients. | Q53508875 |
| | Trends in the sensitivity, positive predictive value, false-positive rate, and comparability ratio of hospital discharge diagnosis codes for acute myocardial infarction in four US communities, 1987-2000 | Q56872705 |
| | Effect of liposomal and free bisphosphonates on the IL-1 beta, IL-6 and TNF alpha secretion from RAW 264 cells in vitro | Q57487673 |
| | High blood pressure and bone-mineral loss in elderly white women: a prospective study | Q58217372 |
| | Developing and validating a diabetes database in a large health system | Q62617483 |
| | Aggregation of hydroxyapatite crystals | Q67529742 |
| | The effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) on necrosis of atherosclerotic lesions | Q70365625 |
| | Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study | Q71730400 |
| | Effects of clodronate (dichloromethylene bisphosphonate) on the development of experimental atherosclerosis in rabbits | Q72469024 |
| | Decrease in carotid intima-media thickness after 1-year therapy with etidronate for osteopenia associated with type 2 diabetes | Q74184760 |
| | Prevalence of comorbid hypertension and dyslipidemia and associated cardiovascular disease | Q81193972 |
| | Alendronate and raloxifene use related to cardiovascular diseases: differentiation by different dosing regimens of alendronate | Q84782451 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myocardial infarction | Q12152 |
| P304 | page(s) | 43-51 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | Mayo Clin Proc | Q6538184 |
| P1476 | title | Myocardial infarction risk among patients with fractures receiving bisphosphonates | |
| P478 | volume | 89 | |